Li, Yufei
Chen, Leichong
Li, Yijin
Luo, Qiang
You, Shuang
Zong, Yan
Li, Qianwen
Cheng, Shaoxian
Meng, Rui
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82373228)
Natural Science Foundation of Hubei Province of China (No.2024AFD440)
Chinese Thoracic Oncology Group (No. CTONG-YC20220118)
Beijing Xisike Clinical Oncology Research Foundation (No. Y-zai2022/ms-0190 and Y-2024AZ(EGFR)MS-0041)
Article History
Received: 25 June 2025
Accepted: 15 December 2025
First Online: 20 January 2026
Declarations
:
: The study was conducted in accordance with the principles of the Declaration of Helsinki principles. The Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology gave a approval for this study. The research was carried out following the guidelines of the ethics committee listed in the ethics statement.
: For any potentially identifiable images, data, or personal information of participants included in this article, written informed consent to publish has been obtained from all relevant individuals.
: Participants involved in this study provided written informed consent to participate after being fully informed of the study’s purpose, procedures, potential risks, and benefits.
: The authors declare no competing interests.